A Phase 1, Open-label, Single-arm Study to Investigate the Effect of Retatrutide on Metoprolol Pharmacokinetics in Healthy Participants
Latest Information Update: 12 Jun 2025
At a glance
- Drugs Retatrutide (Primary) ; Metoprolol
- Indications Cardiovascular disorders; Obesity; Osteoarthritis; Sleep apnoea syndrome; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly and Company
Most Recent Events
- 12 Jun 2025 Last checked against ClinicalTrials.gov record.
- 05 Jun 2025 Status changed from active, no longer recruiting to completed.
- 25 Apr 2025 Status changed from not yet recruiting to active, no longer recruiting.